Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
Gómez-Esteban JC, Tijero B, Somme J, Bilbao I, Fernández J, Boyero S, Velasco F, Lezcano E, Zarranz JJ. Gómez-Esteban JC, et al. Among authors: boyero s. Clin Neurol Neurosurg. 2009 Oct;111(8):665-9. doi: 10.1016/j.clineuro.2009.05.014. Epub 2009 Jul 8. Clin Neurol Neurosurg. 2009. PMID: 19589638
[Baroreflex failure after chemodectoma resection].
Gómez Esteban JC, Boyero S, Fernández C, Sagasta A, Pérez T, Velasco F, Allue I, Lezcano E, Zarranz JJ. Gómez Esteban JC, et al. Among authors: boyero s. Neurologia. 2004 Oct;19(8):452-5. Neurologia. 2004. PMID: 15470587 Spanish.
Use of ziprasidone in parkinsonian patients with psychosis.
Gómez-Esteban JC, Zarranz JJ, Velasco F, Lezcano E, Lachen MC, Rouco I, Barcena J, Boyero S, Ciordia R, Allue I. Gómez-Esteban JC, et al. Among authors: boyero s. Clin Neuropharmacol. 2005 May-Jun;28(3):111-4. doi: 10.1097/01.wnf.0000164297.91643.ff. Clin Neuropharmacol. 2005. PMID: 15965308 Clinical Trial.
[Cerebrovascular disease in a tertiary care hospital. The current situation and points to be improved].
Gómez-Esteban JC, Pérez-Concha T, Zarranz J, Garibi-Undabarrena JM, Gutiérrez G, Velasco F, Larracoechea-Jausoro J, Garamendi I, Losada J, Bilbao I, Boyero S, Fernández M, Mendibe-Bilbao MM, Barcena-Llona J, Rouco-Axpe I, Fernández C, Lezcano-García E, Forcadas-Berdusán MI. Gómez-Esteban JC, et al. Among authors: boyero s. Rev Neurol. 2005 Jun 16-30;40(12):723-8. Rev Neurol. 2005. PMID: 15973637 Free article. Spanish.
Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.
Höftberger R, Titulaer MJ, Sabater L, Dome B, Rózsás A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F. Höftberger R, et al. Among authors: boyero s. Neurology. 2013 Oct 22;81(17):1500-6. doi: 10.1212/WNL.0b013e3182a9585f. Epub 2013 Sep 25. Neurology. 2013. PMID: 24068784 Free PMC article. Review.
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study.
Meca-Lallana JE, Gómez-Ballesteros R, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Maurino J. Meca-Lallana JE, et al. Among authors: boyero s. Neurol Ther. 2022 Sep;11(3):1101-1116. doi: 10.1007/s40120-022-00356-6. Epub 2022 May 6. Neurol Ther. 2022. PMID: 35524037 Free PMC article.
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
Meca-Lallana JE, Maurino J, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Gómez-Ballesteros R, Ballesteros J. Meca-Lallana JE, et al. Among authors: boyero s. PLoS One. 2021 Jul 29;16(7):e0255317. doi: 10.1371/journal.pone.0255317. eCollection 2021. PLoS One. 2021. PMID: 34324586 Free PMC article.
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Meca-Lallana JE, et al. Among authors: boyero s. Patient Prefer Adherence. 2021 Apr 12;15:713-719. doi: 10.2147/PPA.S305707. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33880015 Free PMC article.
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder.
Lopez-Soley E, Meca-Lallana JE, Llufriu S, Blanco Y, Gómez-Ballesteros R, Maurino J, Pérez-Miralles F, Forero L, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Sepulveda M, Solana E. Lopez-Soley E, et al. Among authors: boyero s. J Pers Med. 2022 May 2;12(5):743. doi: 10.3390/jpm12050743. J Pers Med. 2022. PMID: 35629165 Free PMC article.
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder.
Cobo-Calvo Á, Gómez-Ballesteros R, Orviz A, Díaz Sánchez M, Boyero S, Aguado-Valcarcel M, Sepúlveda M, Rebollo P, López-Laiz P, Maurino J, Téllez Lara N. Cobo-Calvo Á, et al. Among authors: boyero s. Front Neurol. 2024 Feb 21;15:1341473. doi: 10.3389/fneur.2024.1341473. eCollection 2024. Front Neurol. 2024. PMID: 38450077 Free PMC article.
11 results